Current evidence on the use of sugammadex for neuromuscular blockade antagonism during electroconvulsive therapy: a narrative review
Depression is a common mental health problem that is associated with significant disability and mortality. Electroconvulsive therapy (ECT) has been demonstrated to be effective at resolving expression of suicidal intent in patients with depression. In less acute situations, patients are usually refe...
Saved in:
| Main Authors: | Vivek Arora, Laurence Henson, Sandeep Kataria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society of Anesthesiologists
2025-02-01
|
| Series: | Korean Journal of Anesthesiology |
| Subjects: | |
| Online Access: | http://ekja.org/upload/pdf/kja-24234.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuromuscular blockade in anaesthesia for maxillofacial cancer surgery: specifics, advantages, challenges and solutions (literary review)
by: T. E. Selina, et al.
Published: (2025-07-01) -
Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients
by: Ji-Yoon Jung, et al.
Published: (2025-01-01) -
Efficacy and Safety of Cisatracurium in Electroconvulsive Therapy: A Randomized, Single-blind, Clinical Trial
by: Siamak Rimaz, et al.
Published: (2024-10-01) -
Risk factors for administration of additional neuromuscular block reversal in adults undergoing general anaesthesia: a single centre retrospective case-control study
by: Susan R. Vishneski, et al.
Published: (2025-04-01) -
Sugammadex or neostigmine for reversal of neuromuscular block on the quality of postoperative recovery in elderly adults undergoing video-assisted thoracoscopic lobectomy: a randomised controlled trial
by: Yu Yang, et al.
Published: (2025-05-01)